EVC
DVAX

Eidelman Virant Capital’s Dynavax Technologies DVAX Stock Holding History

Eidelman Virant Capital’s Portfolio DVAX Stock Details DVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-1,620
Closed -$32K – 187
2013
Q4 		$32K Hold
1,620
– – 0.01% 207
2013
Q3 		$19K Hold
1,620
– – 0.01% 152
2013
Q2 		$18K Buy
+1,620
New +$34.1K 0.01% 150

Other funds holding DVAX

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PC
Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Eidelman Virant Capital's DVAX Position: Q1 2014 in Review

Eidelman Virant Capital sold out of Dynavax Technologies (DVAX) in Q1 2014, closing a stake of 1,620 shares — an estimated $32K sold.

Eidelman Virant Capital first reported a position in DVAX in Q2 2013 and held it in 3 quarters. The position peaked at $32K in Q4 2013. 110 funds tracked by Wall St. Rank hold DVAX as of Q1 2014.

  • Eidelman Virant Capital reported no remaining Dynavax Technologies position as of Q1 2014 after selling out during the quarter.
  • Eidelman Virant Capital sold 1,620 Dynavax Technologies shares in Q1 2014, an estimated $32K.
  • Eidelman Virant Capital first reported a position in Dynavax Technologies in Q2 2013 and held it in 3 quarters.
  • Eidelman Virant Capital's Dynavax Technologies position peaked at $32K in Q4 2013.
  • 110 funds tracked by Wall St. Rank held Dynavax Technologies as of Q1 2014.

Based on Eidelman Virant Capital's 13F filing for Q1 2014, filed 30 Apr 2014.